Skip to main content

Advertisement

SpringerLink
Log in

Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23–24 August 2012

  • Meeting Report
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Joseph K, Tholanikunnel BG, Kaplan AP. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009;124(1):143–9.

    Article  CAS  PubMed  Google Scholar 

  2. Polosa R, Holgate ST. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9] bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990;142(6 Pt 1):1367–71.

    Article  CAS  PubMed  Google Scholar 

  3. Polosa R, Rajakulasingam K, Prosperini G, Milazzo LV, Santonocito G, Holgate ST. Cross-tachyphylactic airway response to inhaled bradykinin, kallidin and [desArg9]-bradykinin in asthmatic subjects. Eur Respir J. 1993;6(5):687–93.

    CAS  PubMed  Google Scholar 

  4. Polosa R, Phillips GD, Lai CK, Holgate ST. Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma. Allergy. 1990;45(3):174–82.

    Article  CAS  PubMed  Google Scholar 

  5. Willis EF, Clough GF, Church MK. Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy. 2004;34(3):450–5.

    Article  CAS  PubMed  Google Scholar 

  6. Rajakulasingam K, Polosa R, Lau LC, Church MK, Holgate ST, Howarth PH. Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax. 1993;48(4):324–9.

    Article  CAS  PubMed  Google Scholar 

  7. Austin CE, Foreman JC. Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency. Br J Clin Pharmacol. 1994;37(1):33–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Clough GF, Bennett AR, Church MK. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol. 1998;138(5):806–14.

    Article  CAS  PubMed  Google Scholar 

  9. Church MK, Bewley AP, Clough GF, Burrows LJ, Ferdinand SI, Petersen LJ. Studies into the mechanisms of dermal inflammation using cutaneous microdialysis. Int Arch Allergy Immunol. 1997;113(1–3):131–3.

    Article  CAS  PubMed  Google Scholar 

  10. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA. 2000;97(14):8140–5.

    Article  CAS  PubMed  Google Scholar 

  11. Cayla C, Todiras M, Iliescu R, Saul VV, Gross V, Pilz B, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J. 2007;21(8):1689–98.

    Article  CAS  PubMed  Google Scholar 

  12. Souza DG, Lomez ES, Pinho V, Pesquero JB, Bader M, Pesquero JL, et al. Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. J Immunol. 2004;172(4):2542–8.

    CAS  PubMed  Google Scholar 

  13. Klein J, Gonzalez J, Duchene J, Esposito L, Pradere JP, Neau E, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J. 2009;23(1):134–42.

    Article  CAS  PubMed  Google Scholar 

  14. Merino VF, Todiras M, Mori MA, Sales VM, Fonseca RG, Saul V, et al. Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E. J Mol Med (Berl). 2009;87(10):953–63.

    Article  CAS  Google Scholar 

  15. Schulze-Topphoff U, Prat A, Prozorovski T, Siffrin V, Paterka M, Herz J, et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat Med. 2009;15(7):788–93.

    Article  CAS  PubMed  Google Scholar 

  16. Raslan F, Schwarz T, Meuth SG, Austinat M, Bader M, Renne T, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood–brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30(8):1477–86.

    Article  CAS  PubMed  Google Scholar 

  17. Trabold R, Eros C, Zweckberger K, Relton J, Beck H, Nussberger J, et al. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2010;30(1):130–9.

    Article  CAS  PubMed  Google Scholar 

  18. Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, et al. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation. 2002;105(3):360–6.

    Article  CAS  PubMed  Google Scholar 

  19. Bader M. Kallikrein-kinin system in neovascularization. Arterioscler Thromb Vasc Biol. 2009;29(5):617–9.

    Article  CAS  PubMed  Google Scholar 

  20. Hillmeister P, Gatzke N, Dulsner A, Bader M, Schadock I, Hoefer I, et al. Arteriogenesis is modulated by bradykinin receptor signaling. Circ Res. 2011;109(5):524–33.

    Article  CAS  PubMed  Google Scholar 

  21. Mori MA, Araujo RC, Reis FC, Sgai DG, Fonseca RG, Barros CC, et al. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes. 2008;57(6):1491–500.

    Article  CAS  PubMed  Google Scholar 

  22. Mori MA, Sales VM, Motta FL, Fonseca RG, Alenina N, Guadagnini D, et al. Kinin B1 receptor in adipocytes regulates glucose tolerance and predisposition to obesity. PLoS One. 2012;7(9):e44782.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Hojima Y, Cochrane CG, Wiggins RC, Austen KF, Stevens RL. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood. 1984;63(6):1453–9.

    CAS  PubMed  Google Scholar 

  24. Oschatz C, Maas C, Lecher B, Jansen T, Bjorkqvist J, Tradler T, et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity. 2011;34(2):258–68.

    Article  CAS  PubMed  Google Scholar 

  25. Renne T, Schmaier AH, Nickel KF, Blomback M, Maas C. In vivo roles of factor XII. Blood. 2012;120(22):4296–303.

    Article  CAS  PubMed  Google Scholar 

  26. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med. 2003;114(4):294–8.

    Article  CAS  PubMed  Google Scholar 

  27. Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199(5):e481–4.

    Article  Google Scholar 

  28. Saule C, Boccon-Gibod I, Fain O, Kanny G, Plu-Bureau G, Martin L, et al. Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy. 2013;43(4):475–82.

    Article  CAS  PubMed  Google Scholar 

  29. Rousset-Jablonski C, Thalabard JC, Gompel A. Tamoxifen contraindicated in women with hereditary angioedema? Ann Oncol. 2009;20(7):1281–2.

    Article  CAS  PubMed  Google Scholar 

  30. Jespersen J, Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen––levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator. Thromb Haemost. 1985;54(2):454–9.

    CAS  PubMed  Google Scholar 

  31. Farsetti A, Misiti S, Citarella F, Felici A, Andreoli M, Fantoni A, et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology. 1995;136(11):5076–83.

    CAS  PubMed  Google Scholar 

  32. Madeddu P, Emanueli C, Song Q, Varoni MV, Demontis MP, Anania V, et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol. 1997;121(8):1763–9.

    Article  CAS  PubMed  Google Scholar 

  33. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin–angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens. 2006;19(7):744–9.

    Article  CAS  PubMed  Google Scholar 

  34. Lamontagne D, Konig A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 1992;20(4):652–7.

    Article  CAS  PubMed  Google Scholar 

  35. O’Kane KP, Webb DJ, Collier JG, Vallance PJ. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol. 1994;38(4):311–5.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Duran WN, Breslin JW, Sanchez FA. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res. 2010;87(2):254–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany

    Markus Magerl, Marcus Maurer & Martin K. Church

  2. Max-Delbrück-Center for Molecular Medicine (MDC), Charité-Universitätsmedizin, Berlin, Germany

    Michael Bader

  3. Gynaecology Department, Paris Descartes University, Port Royal Cochin, APHP, Paris, France

    Anne Gompel

  4. Medical University of South Carolina, Charleston, SC, USA

    Kusumam Joseph & Allen P. Kaplan

  5. Institute for Pharmacology and Clinical Pharmacology, University Hospital, Heinrich-Heine-University, Dusseldorf, Germany

    Georg Kojda

  6. Department of Molecular Medicine and Surgery and Center of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

    Thomas Renné

  7. Institute for Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany

    Thomas Renné

  8. HNO Klinik, Klinikum rechts der Isar der TU München, Munich, Germany

    Markus Wirth

Authors
  1. Markus Magerl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Gompel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kusumam Joseph
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Allen P. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georg Kojda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Thomas Renné
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Markus Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marcus Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Martin K. Church
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin K. Church.

Additional information

Responsible Editor: John Di Battista.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magerl, M., Bader, M., Gompel, A. et al. Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23–24 August 2012. Inflamm. Res. 63, 173–178 (2014). https://doi.org/10.1007/s00011-013-0693-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-013-0693-1

Keywords

Search

Navigation